Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Return on Sales: 2011-2018

Historic Return on Sales for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Sep 2018 value amounting to -15.54%.

  • EyePoint Pharmaceuticals' Return on Sales fell 1327.00% to -15.54% in Q3 2018 from the same period last year, while for Sep 2018 it was -15.54%, marking a year-over-year decrease of 1327.00%. This contributed to the annual value of -17.96% for FY2018, which is 1551.00% down from last year.
  • EyePoint Pharmaceuticals' Return on Sales amounted to -15.54% in Q3 2018, which was down 25.86% from -12.35% recorded in Q2 2018.
  • In the past 5 years, EyePoint Pharmaceuticals' Return on Sales ranged from a high of 0.39% in Q3 2014 and a low of -16.61% during Q3 2016.
  • Over the past 3 years, EyePoint Pharmaceuticals' median Return on Sales value was -10.80% (recorded in 2016), while the average stood at -9.30%.
  • Per our database at Business Quant, EyePoint Pharmaceuticals' Return on Sales plummeted by 1,360bps in 2016 and then spiked by 1,435bps in 2017.
  • EyePoint Pharmaceuticals' Return on Sales (Quarterly) stood at 0.37% in 2014, then tumbled by 1,112bps to -10.75% in 2015, then surged by 804bps to -2.71% in 2016, then slumped by 1,028bps to -12.99% in 2017, then crashed by 1,327bps to -15.54% in 2018.
  • Its Return on Sales stands at -15.54% for Q3 2018, versus -12.35% for Q2 2018 and -10.69% for Q1 2018.